Somatodendritic accumulation of Tau in Alzheimer's disease is promoted by Fyn‐mediated local protein translation
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 1×
“Here, oligomeric A b (A b o) is believed to be a major neurotoxic species, causing synaptic dysfunction and neurodegeneration by a so far incompletely understood mechanism (Lesne et al , 2006; Shankar et al , 2008; Walsh et al , 2002).”
RetractedLarson, M., Sherman, M. A., Amar, F., Nuvolone, M., Schneider, J. A., Bennett, D. A., Aguzzi, A., & Lesné, S. E. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1858-12.2012 · Cited by 277 · cited 4×
“A role for Fyn in mediating A b o toxicity is further supported by studies in cultured neurons (Larson et al , 2012; Um et al , 2013, 2012).”
InfluentialRetractedWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · cited 1×
“Here, oligomeric A b (A b o) is believed to be a major neurotoxic species, causing synaptic dysfunction and neurodegeneration by a so far incompletely understood mechanism (Lesne et al , 2006; Shankar et al , 2008; Walsh et al , 2002).”
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685 · cited 1×
“Here, oligomeric A b (A b o) is believed to be a major neurotoxic species, causing synaptic dysfunction and neurodegeneration by a so far incompletely understood mechanism (Lesne et al , 2006; Shankar et al , 2008; Walsh et al , 2002).”
Bloom (2014) · doi:10.1001/jamaneurol.2013.5847 · Cited by 2,194 · cited 1×
“A large number of studies have addressed the link between these lesions, placing A b upstream of Tau in a patho-cascade (Bloom, 2014; Frandemiche et al , 2014; Jin et al , 2011; Pooler et al , 2015).”
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.036 · Cited by 1,821 · cited 3×
“Fyn has also been shown to be targeted to dendritic spines by Tau, a process that is facilitated by the interaction of Tau with the SH3 domain of Fyn, and of tyrosine-phosphorylated Tau with the SH2 domain of Fyn (Ittner et al , 2010; Lee et al , 2004; Usardi et al , 2011).”
Self-citationTwo amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507 · cited 1×
“…mice (Stein et al , 1992), Fyn transgenic mice (FynCA Tg) expressing a constitutively active Y531F mutant form of human Fyn (Xia & Go¨tz, 2014), and APP23 mice expressing the human APP transgene containing the Swedish mutation (KM670/671NL) (Sturchler-Pierrat et al , 1997) were used in this study.”
In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis
Stine, W. B., Dahlgren, K. N., Krafft, G. A., & LaDu, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210207200 · Cited by 1,015 · cited 1×
“A b peptides were mixed thoroughly with cold F12 medium at a final concentration of 100 l M and then incubated at 4 ° C for 24 h to allow oligomerization or incubated at room temperature for 7 days to allow fibrillization (Stine et al , 2003).”
Morris, M., Maeda, S., Vossel, K., & Mucke, L. (2011) · Neuron · doi:10.1016/j.neuron.2011.04.009 · Cited by 899 · cited 1×
“This is not surprising, as Tau is known to exert such a function and interact with a range of different proteins (Klein et al , 2002; Sharma et al , 2007; Morris et al , 2011).”
Jin, M., Shepardson, N., Yang, T., Chen, G., Walsh, D., & Selkoe, D. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017033108 · Cited by 876 · cited 1×
“A large number of studies have addressed the link between these lesions, placing A b upstream of Tau in a patho-cascade (Bloom, 2014; Frandemiche et al , 2014; Jin et al , 2011; Pooler et al , 2015).”
Translational Control by MAPK Signaling in Long-Term Synaptic Plasticity and Memory
Kelleher, R. J., Govindarajan, A., Jung, H.-Y., Kang, H., & Tonegawa, S. (2004) · Cell · doi:10.1016/s0092-8674(04)00115-1 · Cited by 845 · cited 2×
“MAP kinases and the ribosomal protein S6 have been implicated in the general regulation of new protein synthesis (Kelleher et al , 2004; Pende et al , 2004), with strong evidence that S6 activation occurs downstream of MAPK and requires Fyn activity (Salmond et al , 2009).”
Pende, M., Um, S. H., Mieulet, V., Sticker, M., Goss, V. L., Mestan, J., Mueller, M., Fumagalli, S., Kozma, S. C., & Thomas, G. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3112-3124.2004 · Cited by 742 · cited 1×
“MAP kinases and the ribosomal protein S6 have been implicated in the general regulation of new protein synthesis (Kelleher et al , 2004; Pende et al , 2004), with strong evidence that S6 activation occurs downstream of MAPK and requires Fyn activity (Salmond et al , 2009).”
Roux, P. P., Shahbazian, D., Vu, H., Holz, M. K., Cohen, M. S., Taunton, J., Sonenberg, N., & Blenis, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700906200 · Cited by 702 · cited 1×
“Therefore, considering the previously reported evidence of an mTOR-independent Ras/ERK/S6 signaling pathway (Roux et al , 2007), we hypothesized a role for Fyn in increasing Tau protein levels by activating the ERK/S6 signaling cascade.”
Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons
Um, J. W., Nygaard, H. B., Heiss, J. K., Kostylev, M. A., Stagi, M., Vortmeyer, A., Wisniewski, T., Gunther, E. C., & Strittmatter, S. M. (2012) · Nature Neuroscience · doi:10.1038/nn.3178 · Cited by 662 · cited 4×
“A role for Fyn in mediating A b o toxicity is further supported by studies in cultured neurons (Larson et al , 2012; Um et al , 2013, 2012).”
InfluentialRoberson, E. D., Halabisky, B., Yoo, J. W., Yao, J., Chin, J., Yan, F., Wu, T., Hamto, P., Devidze, N., Yu, G.-Q., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4152-10.2011 · Cited by 654 · cited 1×
“With disease progression, Tau levels increase, mediating the toxic effects of A b in the dendritic compartment, and thereby establishing a feedback loop (Ittner et al , 2010; Roberson et al , 2011).”
Control of local protein synthesis and initial events in myelination by action potentials
Wake, H., Lee, P. R., & Fields, R. D. (2011) · Science · doi:10.1126/science.1206998 · Cited by 636 · cited 1×
“Fyn has also been implicated in local protein translation in oligodendrocytes (Wake et al , 2011; White et al , 2008).”
Um, J. W., Kaufman, A. C., Kostylev, M., Heiss, J. K., Stagi, M., Takahashi, H., Kerrisk, M. E., Vortmeyer, A., Wisniewski, T., Koleske, A. J., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.06.036 · Cited by 572 · cited 4×
“A role for Fyn in mediating A b o toxicity is further supported by studies in cultured neurons (Larson et al , 2012; Um et al , 2013, 2012).”
Influentialpp59fyn mutant mice display differential signaling in thymocytes and peripheral T cells
Stein, P. L., Lee, H.-M., Rich, S., & Soriano, P. (1992) · Cell · doi:10.1016/0092-8674(92)90308-y · Cited by 568 · cited 1×
“Wild-type (WT) C57BL/6 mice, Fyn-knockout (FynKO) mice (Stein et al , 1992), Fyn transgenic mice (FynCA Tg) expressing a constitutively active Y531F mutant form of human Fyn (Xia & Go¨tz, 2014), and APP23 mice expressing the human APP transgene containing the Swedish mutation (KM670/671NL)…”
Wang, J.-Z., Xia, Y.-Y., Grundke-Iqbal, I., & Iqbal, K. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-129031 · Cited by 532 · cited 1×
“In AD and related tauopathies, Tau accumulates in both the soma and the dendrites in a hyperphosphorylated form (Wang et al , 2013).”
Milnerwood, A. J., Gladding, C. M., Pouladi, M. A., Kaufman, A. M., Hines, R. M., Boyd, J. D., Ko, R. W. Y., Vasuta, O. C., Graham, R. K., Hayden, M. R., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.008 · Cited by 517 · cited 1×
“Subcellular fractionation was performed with slight modifications of a previously described method (Milnerwood et al , 2010).”
Olsson, A., Vanderstichele, H., Andreasen, N., De Meyer, G., Wallin, A., Holmberg, B., Rosengren, L., Vanmechelen, E., & Blennow, K. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.039347 · Cited by 437 · cited 1×
“This even extends to human patients, where Tau levels in the CSF of AD patients, but not patients with frontotemporal dementia (another tauopathy), rise steeply pointing at A b as a driver of Tau increases in AD (Hampel et al , 2004; Olsson et al , 2005).”
Hampel, H., Buerger, K., Zinkowski, R., Teipel, S. J., Goernitz, A., Andreasen, N., Sjoegren, M., DeBernardis, J., Kerkman, D., Ishiguro, K., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.95 · Cited by 434 · cited 1×
“This even extends to human patients, where Tau levels in the CSF of AD patients, but not patients with frontotemporal dementia (another tauopathy), rise steeply pointing at A b as a driver of Tau increases in AD (Hampel et al , 2004; Olsson et al , 2005).”
Phosphorylation of Tau by Fyn: Implications for Alzheimer's Disease
Lee, G., Thangavel, R., Sharma, V. M., Litersky, J. M., Bhaskar, K., Fang, S. M., Do, L. H., Andreadis, A., Van Hoesen, G., & Ksiezak-Reding, H. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4162-03.2004 · Cited by 414 · cited 2×
“Fyn has also been shown to be targeted to dendritic spines by Tau, a process that is facilitated by the interaction of Tau with the SH3 domain of Fyn, and of tyrosine-phosphorylated Tau with the SH2 domain of Fyn (Ittner et al , 2010; Lee et al , 2004; Usardi et al , 2011).”
Kosik, K., & Finch, E. (1987) · The Journal of Neuroscience · doi:10.1523/jneurosci.07-10-03142.1987 · Cited by 368 · cited 3×
“Early in development, Tau is distributed throughout the neuron; with maturation, however, it becomes enriched in the axon (Kosik & Finch, 1987).”
InfluentialFyn inhibition rescues established memory and synapse loss in Alzheimer mice
Kaufman, A. C., Salazar, S. V., Haas, L. T., Yang, J., Kostylev, M. A., Jeng, A. T., Robinson, S. A., Gunther, E. C., van Dyck, C. H., Nygaard, H. B., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24394 · Cited by 314 · cited 1×
“…protein (APP) transgenic mouse models, Fyn accelerates synaptic and cognitive impairment (Chin et al , 2005), whereas synaptic degeneration and memory loss are rescued when Fyn is either depleted or its activity is suppressed in an APP mutant background (Chin et al , 2004; Kaufman et al , 2015).”
Chin, J., Palop, J. J., Puoliväli, J., Massaro, C., Bien-Ly, N., Gerstein, H., Scearce-Levie, K., Masliah, E., & Mucke, L. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2980-05.2005 · Cited by 312 · cited 1×
“When overexpressed in human A b -forming amyloid precursor protein (APP) transgenic mouse models, Fyn accelerates synaptic and cognitive impairment (Chin et al , 2005), whereas synaptic degeneration and memory loss are rescued when Fyn is either depleted or its activity is suppressed in an APP…”
Direct visualization of newly synthesized target proteins in situ
tom Dieck, S., Kochen, L., Hanus, C., Heumüller, M., Bartnik, I., Nassim-Assir, B., Merk, K., Mosler, T., Garg, S., Bunse, S., et al. (2015) · Nature Methods · doi:10.1038/nmeth.3319 · Cited by 303 · cited 2×
“A technique that combines PLA with puromycin (Puro) labeling was recently developed to trace newly synthesized target proteins in situ (Tom Dieck et al , 2015).”
Zempel, H., Luedtke, J., Kumar, Y., Biernat, J., Dawson, H., Mandelkow, E., & Mandelkow, E. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.207 · Cited by 283 · cited 1×
“…from the microtubules and passes through the axon initial segment, which serves as a diffusion barrier for physiologically phosphorylated Tau, before accumulating in the cell body and dendrites, a process that is partly mediated by A b (Li et al , 2011; Sohn et al , 2016; Zempel et al , 2013).”
Frandemiche, M. L., De Seranno, S., Rush, T., Borel, E., Elie, A., Arnal, I., Lanté, F., & Buisson, A. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4261-13.2014 · Cited by 272 · cited 2×
“Considering that Tau accumulates in dendritic spines under conditions of neuronal activation (Frandemiche et al , 2014), together with the role that local protein translation has in the dendrite (Tom Dieck et al , 2014), and the fact that Fyn regulates activity-dependent trafficking (Brigidi et al…”
Lost after translation: missorting of Tau protein and consequences for Alzheimer disease
Zempel, H., & Mandelkow, E. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.08.004 · Cited by 265 · cited 1×
“…of the Fyn/ERK/ S6/Tau pathway also occurs in neurons, in which A b o is thought to trigger the relocalization of hyperphosphorylated Tau from the axon to the somatodendritic domain, where Tau is found to accumulate in AD and related tauopathies (Li et al , 2011; Zempel & Mandelkow, 2014).”
Klein, C., Krämer, E.-M., Cardine, A.-M., Schraven, B., Brandt, R., & Trotter, J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00698.2002 · Cited by 250 · cited 1×
“This is not surprising, as Tau is known to exert such a function and interact with a range of different proteins (Klein et al , 2002; Sharma et al , 2007; Morris et al , 2011).”
Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease
Pooler, A. M., Polydoro, M., Maury, E. A., Nicholls, S. B., Reddy, S. M., Wegmann, S., William, C., Saqran, L., Cagsal-Getkin, O., Pitstick, R., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0199-x · Cited by 236 · cited 1×
“A large number of studies have addressed the link between these lesions, placing A b upstream of Tau in a patho-cascade (Bloom, 2014; Frandemiche et al , 2014; Jin et al , 2011; Pooler et al , 2015).”
Novel diffusion barrier for axonal retention of Tau in neurons and its failure in neurodegeneration
Li, X., Kumar, Y., Zempel, H., Mandelkow, E., Biernat, J., & Mandelkow, E. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.376 · Cited by 223 · cited 2×
“…of the Fyn/ERK/ S6/Tau pathway also occurs in neurons, in which A b o is thought to trigger the relocalization of hyperphosphorylated Tau from the axon to the somatodendritic domain, where Tau is found to accumulate in AD and related tauopathies (Li et al , 2011; Zempel & Mandelkow, 2014).”
An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice
Le Corre, S., Klafki, H. W., Plesnila, N., Hübinger, G., Obermeier, A., Sahagún, H., Monse, B., Seneci, P., Lewis, J., Eriksen, J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602913103 · Cited by 221 · cited 1×
“Interestingly, it has been reported in Tau transgenic mice that an ERK inhibitor not only reduced the levels of hyperphosphorylated, but also total human Tau, suggesting a role for ERK in regulating Tau expression (Le Corre et al , 2006).”
Primary support cultures of hippocampal and substantia nigra neurons
Fath, T., Ke, Y. D., Gunning, P., Götz, J., & Ittner, L. M. (2009) · Nature Protocols · doi:10.1038/nprot.2008.199 · Cited by 215 · cited 1×
“Hippocampal neurons from WT and FynKO mouse embryos were obtained at embryonic day 17 (E17) and plated in 12-well plates on coverslips coated with poly-D-lysine (PDL) at a density of The EMBO Journal 80,000 cells/well (Fath et al , 2009).”
Self-citationMaia, L. F., Kaeser, S. A., Reichwald, J., Hruscha, M., Martus, P., Staufenbiel, M., & Jucker, M. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006446 · Cited by 204 · cited 1×
“In support of our observations, total endogenous Tau levels in CSF are threefold increased in APP23 mice at a stage when A b pathology becomes prominent (Maia et al , 2013).”
White, R., Gonsior, C., Krämer-Albers, E.-M., Stöhr, N., Hüttelmaier, S., & Trotter, J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200706164 · Cited by 199 · cited 2×
“Fyn has also been implicated in local protein translation in oligodendrocytes (Wake et al , 2011; White et al , 2008).”
Regulation of NMDA receptors by the tyrosine kinase Fyn
Trepanier, C. H., Jackson, M. F., & MacDonald, J. F. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08391.x · Cited by 197 · cited 1×
“Fyn is widely expressed in the hippocampus, integrating various signaling pathways and having a critical modulatory effect on synaptic protein trafficking (Ohnishi et al , 2011), as well as synaptic plasticity and learning (Trepanier et al , 2012).”
Meier, S., Bell, M., Lyons, D. N., Rodriguez-Rivera, J., Ingram, A., Fontaine, S. N., Mechas, E., Chen, J., Wolozin, B., LeVine, H., et al. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.3029-15.2016 · Cited by 190 · cited 1×
“More specifically, an increased association between Tau and ribosomes has been reported in AD compared to control brains (Meier et al , 2016), as well as the presence of two new ERK2 docking motifs in Tau that regulate ERK binding and Tau phosphorylation (Qi et al , 2016).”
Litman, P., Barg, J., Rindzoonski, L., & Ginzburg, I. (1993) · Neuron · doi:10.1016/0896-6273(93)90165-n · Cited by 178 · cited 1×
“It has previously been shown that, unlike Map2 mRNA , which is confined to the soma and dendrites in young primary neuronal cultures, Mapt mRNA localizes to the soma and the proximal axon (Litman et al , 1993).”
Chin, J., Palop, J. J., Yu, G.-Q., Kojima, N., Masliah, E., & Mucke, L. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0277-04.2004 · Cited by 161 · cited 1×
“…protein (APP) transgenic mouse models, Fyn accelerates synaptic and cognitive impairment (Chin et al , 2005), whereas synaptic degeneration and memory loss are rescued when Fyn is either depleted or its activity is suppressed in an APP mutant background (Chin et al , 2004; Kaufman et al , 2015).”
Sohn, P. D., Tracy, T. E., Son, H.-I., Zhou, Y., Leite, R. E. P., Miller, B. L., Seeley, W. W., Grinberg, L. T., & Gan, L. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0109-0 · Cited by 160 · cited 1×
“…from the microtubules and passes through the axon initial segment, which serves as a diffusion barrier for physiologically phosphorylated Tau, before accumulating in the cell body and dendrites, a process that is partly mediated by A b (Li et al , 2011; Sohn et al , 2016; Zempel et al , 2013).”
Activity-regulated trafficking of the palmitoyl-acyl transferase DHHC5
Brigidi, G. S., Santyr, B. G., Shimell, J. J., Jovellar, D. B., & Bamji, S. X. (2015) · Nature Communications · doi:10.1038/ncomms9200 · Cited by 136 · cited 1×
“…(Frandemiche et al , 2014), together with the role that local protein translation has in the dendrite (Tom Dieck et al , 2014), and the fact that Fyn regulates activity-dependent trafficking (Brigidi et al , 2015), it is plausible that Fyn and local protein synthesis are tightly coupled via Tau.”
Src family kinases: modulators of neurotransmitter receptor function and behavior
Ohnishi, H., Murata, Y., Okazawa, H., & Matozaki, T. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.09.005 · Cited by 118 · cited 2×
“Fyn is widely expressed in the hippocampus, integrating various signaling pathways and having a critical modulatory effect on synaptic protein trafficking (Ohnishi et al , 2011), as well as synaptic plasticity and learning (Trepanier et al , 2012).”
Salmond, R. J., Emery, J., Okkenhaug, K., & Zamoyska, R. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902294 · Cited by 115
Caccamo, A., Branca, C., Talboom, J. S., Shaw, D. M., Turner, D., Ma, L., Messina, A., Huang, Z., Wu, J., & Oddo, S. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2781-15.2015 · Cited by 105 · cited 1×
“Furthermore, genetic reduction of S6 kinase in mice was found to improve synaptic plasticity and spatial memory deficits and reduce A b and Tau accumulation (Caccamo et al , 2015).”
Kosik, K. S., Crandall, J. E., Mufson, E. J., & Neve, R. L. (1989) · Annals of Neurology · doi:10.1002/ana.410260308 · Cited by 92 · cited 3×
“…of whether they were MAP2-positive (dendrites) or As an additional experimental system to address subcellular localization, we used a microfluidic device that is ideally suited to discriminate axons (Tau-positive) and dendrites (MAP2-positive) based on their length (Fig EV4B (Kosik et al , 1989).”
InfluentialGentry, E. G., Henderson, B. W., Arrant, A. E., Gearing, M., Feng, Y., Riddle, N. C., & Herskowitz, J. H. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2336-15.2016 · Cited by 90 · cited 1×
“S6 kinase (and the mTOR pathway) has been shown to be also activated in progressive supranuclear palsy and corticobasal degeneration, two tauopathies characterized by pronounced glial pathology (Gentry et al , 2016).”
Usardi, A., Pooler, A. M., Seereeram, A., Reynolds, C. H., Derkinderen, P., Anderton, B., Hanger, D. P., Noble, W., & Williamson, R. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08218.x · Cited by 89 · cited 2×
“Fyn has also been shown to be targeted to dendritic spines by Tau, a process that is facilitated by the interaction of Tau with the SH3 domain of Fyn, and of tyrosine-phosphorylated Tau with the SH2 domain of Fyn (Ittner et al , 2010; Lee et al , 2004; Usardi et al , 2011).”
Xia, D., Li, C., & Götz, J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.12.017 · Cited by 89 · cited 1×
“Tau-V5 and Fyn-Myc constructs were generated from pENTR donor vectors that contained full-length human 2N4R Tau (hTau40, 441 aa) and full-length human Fyn as described previously (Xia et al , 2015).”
Self-citationTau impacts on growth-factor-stimulated actin remodeling
Sharma, V. M., Litersky, J. M., Bhaskar, K., & Lee, G. (2007) · Journal of Cell Science · doi:10.1242/jcs.03378 · Cited by 75 · cited 1×
“This is not surprising, as Tau is known to exert such a function and interact with a range of different proteins (Klein et al , 2002; Sharma et al , 2007; Morris et al , 2011).”
Characterization of Neuronal Tau Protein as a Target of Extracellular Signal-regulated Kinase
Qi, H., Prabakaran, S., Cantrelle, F.-X., Chambraud, B., Gunawardena, J., Lippens, G., & Landrieu, I. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.700914 · Cited by 67 · cited 1×
“More specifically, an increased association between Tau and ribosomes has been reported in AD compared to control brains (Meier et al , 2016), as well as the presence of two new ERK2 docking motifs in Tau that regulate ERK binding and Tau phosphorylation (Qi et al , 2016).”
Xia, D., & Götz, J. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00040 · Cited by 29 · cited 2×
“We have previously generated a transgenic mouse strain that overexpresses a Myc-tagged constitutively active form of Fyn (FynCA Tg) driven by the neuronal mThy 1.2 promoter (Xia & Go¨tz, 2014).”
InfluentialSelf-citationSnapShot: Local Protein Translation in Dendrites
Dieck, S. T., Hanus, C., & Schuman, E. M. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.009 · Cited by 24 · cited 1×
“…under conditions of neuronal activation (Frandemiche et al , 2014), together with the role that local protein translation has in the dendrite (Tom Dieck et al , 2014), and the fact that Fyn regulates activity-dependent trafficking (Brigidi et al , 2015), it is plausible that Fyn and local…”
Cited by
Tau protein liquid–liquid phase separation can initiate tau aggregation
Wegmann, S., Eftekharzadeh, B., Tepper, K., Zoltowska, K. M., Bennett, R. E., Dujardin, S., Laskowski, P. R., MacKenzie, D., Kamath, T., Commins, C., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201798049 · Cited by 1,102
Local translation in neurons: visualization and function
Holt, C. E., Martin, K. C., & Schuman, E. M. (2019) · Nature Structural & Molecular Biology · doi:10.1038/s41594-019-0263-5 · Cited by 534
Synaptic degeneration in Alzheimer disease
Tzioras, M., McGeachan, R. I., Durrant, C. S., & Spires-Jones, T. L. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-022-00749-z · Cited by 504
Rodent models for Alzheimer disease
Götz, J., Bodea, L.-G., & Goedert, M. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0054-8 · Cited by 394
Self-citationAmyloid-β and tau complexity — towards improved biomarkers and targeted therapies
Polanco, J. C., Li, C., Bodea, L.-G., Martinez-Marmol, R., Meunier, F. A., & Götz, J. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.162 · Cited by 378
Self-citation
Metadata
- Authors
- Li, C., & Götz, J.
- Venue
- The EMBO Journal
- Published
- 2017-09
- Volume
- 36
- Issue
- 21
- Pages
- 3120-3138
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W2751201591
- Cited by
- 178
- References
- 54
- FWCI
- 12.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.